These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 8971176)
1. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis. Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589 [TBL] [Abstract][Full Text] [Related]
3. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217 [TBL] [Abstract][Full Text] [Related]
4. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597 [TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Castle VP; Dixit VM; Polverini PJ Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678 [TBL] [Abstract][Full Text] [Related]
7. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104 [TBL] [Abstract][Full Text] [Related]
8. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633 [TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
11. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042 [TBL] [Abstract][Full Text] [Related]
12. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Weinstat-Saslow DL; Zabrenetzky VS; VanHoutte K; Frazier WA; Roberts DD; Steeg PS Cancer Res; 1994 Dec; 54(24):6504-11. PubMed ID: 7527299 [TBL] [Abstract][Full Text] [Related]
13. Molecular mediators of angiogenesis in bladder cancer. Campbell SC; Volpert OV; Ivanovich M; Bouck NP Cancer Res; 1998 Mar; 58(6):1298-304. PubMed ID: 9515819 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205 [TBL] [Abstract][Full Text] [Related]
15. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators. Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569 [TBL] [Abstract][Full Text] [Related]
16. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592 [TBL] [Abstract][Full Text] [Related]
18. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101 [TBL] [Abstract][Full Text] [Related]
19. Decorin suppresses tumor cell-mediated angiogenesis. Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415 [TBL] [Abstract][Full Text] [Related]
20. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]